The University of Chicago Header Logo

Connection

Nicholas Ollberding to Rituximab

Back to Details
This is a "connection" page, showing publications Nicholas Ollberding has written about Rituximab.
Nicholas Ollberding
Connection Strength
0.027
Rituximab
  1. A systematic review of comparative schedule-related toxicities with maintenance rituximab in follicular and mantle cell lymphomas. Leuk Lymphoma. 2014 Jun; 55(6):1288-94.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.